Combe unveils Preventeza Emergency Contraceptive campaign

Print Friendly, PDF & Email
WHITE PLAINS, N.Y. — Combe Inc., the makers of Vagisil, announced the launch of its Preventeza Emergency Contraceptive (levonorgestrel tablet, 1.5 mg) #WeAre1in2 campaign to showcase solidarity around women’s reproductive rights.

To demonstrate its commitment to helping women learn more about emergency contraception (EC), the company is planning to give away up to $1 million worth of free product via the launch of its “Buy One Get One or Give One (BoGoGo)” product campaign where women who purchase Preventeza on Vagisil.com will have the option to get a second one for free to either keep on hand or to give to another woman in their life.

New Preventeza by Vagisil, available online or over-the-counter  as a single tablet, takes the panic out of a stressful moment, and is a proven option to help women prevent pregnancy before it starts by using the same ingredient as most birth control pills, just at a higher dose. By keeping Preventeza on hand, women can always be prepared and in control.

“We are thrilled about the BoGoGo promotion as it provides us with the opportunity to educate women about the need for and the importance of access to emergency contraception (EC). Moreover, it remains shocking to us that while 1 in 2 women may need an EC in their lifetime, only 10 percent of women have actually used it,” said Keech Combe Shetty, CEO of Vagisil. “This is why we are giving away up to $1 million worth of Preventeza as it aligns with our mission at Vagisil to empower women to take ownership of their reproductive health without shame.”

Preventeza’s BoGoGo promotion is available nationwide and can be activated at checkout online at Vagisil.com. In parallel, the company is launching the #WeAre1in2 campaign on social media that is aimed at increasing awareness of the fact that 1 in 2 women may need EC in their lifetime due to the risk of unintended pregnancies. People are encouraged to showcase their solidarity using #WeAre1in2 on social media.

“It is an important time in the history of our country for women to gather together on critical issues related to reproductive health. The fact that 45 percent of pregnancies remain unplanned or mistimed clearly demonstrates the need for education so women can understand that there are safe and effective tools that serve as back-ups for regular birth control in case of unprotected sex or when birth control fails. In addition to practicing safe sex, there are EC options, such as Vagisil’s Preventeza, available to all women of reproductive age,” said Logan Levkoff, PhD, MS, an internationally recognized expert on sexuality and relationships. “I am proud that Preventeza is launching a dialogue on this timely movement that will help to differentiate myths versus facts about EC while increasing access for all women.”




Comments are closed.